Synthetic CKD Validation Library
Fully de-identified synthetic cases used to demonstrate deterministic CKD pattern behavior, AKI safety gating, CGA classification, and medication-safety routing. These cases do not represent validated real-world diagnostic performance.
Persistent moderately increased albuminuria with preserved GFR
Detect confirmed early CKD without reduced eGFR
Persistent severely increased albuminuria with mildly decreased GFR
Ensure G2A3 is not collapsed into A2
Single reduced eGFR without chronicity
Prevent false-positive CKD confirmation
Acute creatinine rise before CKD staging
Run AKI gate first
Isolated suspected G3a requiring cystatin C confirmation support
Confirm eGFRcr-cys workflow
Combined eGFR reclassification support
Use combined equation when cystatin C available
Confirmed CKD G3bA3 with diabetes
Detect high-risk diabetic kidney disease pattern
Active glomerular disease red flag
Flag urgent glomerular pattern rather than benign CKD stage only
Anemia in CKD context without overdiagnosing EPO deficiency
Require workup before causal claim
Vitamin D low alone does not establish CKD-MBD
Prevent inappropriate CKD-MBD treatment output
Load caseSevere potassium elevation with eGFR unknown
Fire global safety alert independently of CKD status
Metformin contraindication threshold
Apply FDA renal impairment safety logic
Kidney failure range does not automatically mandate dialysis
Avoid unsafe KRT statement
Possible monoclonal protein-related kidney disease
Use UACR/uPCR discrepancy and systemic features
ACE inhibitor monitoring rather than automatic cessation
Support guideline-concordant medication stewardship
ACE inhibitor creatinine rise requiring evaluation
Flag >30% change without automatic stop statement
UACR positive random sample requires confirmation
Implement sample-specific confirmation logic
Transient UACR confounder
Prevent albuminuria diagnosis during active UTI
Possible obstructive kidney process
Detect reversible etiologic concern
SGLT2i early eGFR dip
Prevent misclassification as drug harm without red flags